CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The goal of this clinical trial is to treat male and female participants with two types of Multiple Sclerosis (MS) called ...
Phase 1, Phase 2
Kansas City, Kansas, United States and 1 other location
treatment with natalizumab in patients with relapsing-remitting multiple sclerosis (RRMS) and active secondary progressive multiple...
Phase 4
Overland Park, Kansas, United States and 1 other location
The purpose of this study is to provide efficacy and safety data for remibrutinib in patients with secondary progressive multiple sclerosis...
Phase 3
Kansas City, Kansas, United States and 43 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Overland Park, Kansas, United States and 201 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Kansas City, Kansas, United States and 228 other locations
of remibrutinib after switching from ocrelizumab and compared to continuous ocrelizumab treatment, in patients living with relapsing multiple...
Phase 3
Kansas City, Kansas, United States and 85 other locations
) neo-antigen in subjects with relapsing multiple sclerosis (RMS).COVID-19 sub-study:The purpose of this research sub-study is to e...
Phase 3
Kansas City, Kansas, United States and 298 other locations
This is a Phase 3 extension, global, multicenter study to assess the long-term safety and tolerability of tolebrutinib in adult participants (aged ≥1...
Phase 3
Kansas City, Kansas, United States and 352 other locations
This study will evaluate the efficacy and safety of ocrelizumab (Ocrevus®) compared with placebo in participants with primary progressive multiple...
Phase 3
Kansas City, Kansas, United States and 158 other locations
Clinical trials
Research sites
Resources
Legal